Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name RO6958688
Trade Name
Synonyms RG7802|Cibisatamab|CEA-TCB|RO-6958688
Drug Descriptions

RO6958688 (Cibisatamab) is a bispecific antibody that binds to CD3 and human anti-carcinoembryonic antigen (CEA) simultaneously, which may lead to cytotoxic immune response against CEA-positive tumor cells (PMID: 30982469).

CAS Registry Number 1855925-27-7
NCIT ID C120097


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Atezolizumab + Obinutuzumab + RO6958688 Atezolizumab Obinutuzumab RO6958688 0 1
Atezolizumab + RO6958688 Atezolizumab RO6958688 0 2
Obinutuzumab + RO6958688 + RO7122290 Obinutuzumab RO6958688 RO7122290 0 1
RO6958688 RO6958688 0 0

Additional content available in CKB BOOST